Cargando…

Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020–2116

Objective: To model the effects of demographic change under various scenarios of possible future treatment developments in ALS. Methods: Patients diagnosed with ALS at the King’s College Hospital Motor Nerve Clinic between 2004 and 2017, and living within the London boroughs of Lambeth, Southwark, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gowland, Alison, Opie-Martin, Sarah, Scott, Kirsten M., Jones, Ashley R., Mehta, Puja R., Batts, Christine J., Ellis, Cathy M., Leigh, P. Nigel, Shaw, Christopher E., Sreedharan, Jemeen, Al-Chalabi, Ammar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567553/ https://www.ncbi.nlm.nih.gov/pubmed/30961394 http://dx.doi.org/10.1080/21678421.2019.1587629

Ejemplares similares

Relative preservation of triceps over biceps strength in upper limb-onset ALS: the ‘split elbow’
por: Khalaf, Roaya, et al.
Publicado: (2019)

A clinical tool for predicting survival in ALS
por: Knibb, Jonathan A, et al.
Publicado: (2016)

Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups
por: Ganesalingam, Jeban, et al.
Publicado: (2009)

Comparison of the King’s and MiToS staging systems for ALS
por: Fang, Ton, et al.
Publicado: (2017)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Schalkwijk, Casper G., et al.
Publicado: (2013)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Yamagishi, Sho-ichi
Publicado: (2013)

Does genetic anticipation occur in familial Alexander disease?
por: Hunt, Camille K., et al.
Publicado: (2021)

Response to Comments on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Selvin, Elizabeth, et al.
Publicado: (2013)

The era of cryptic exons: implications for ALS-FTD
por: Mehta, Puja R., et al.
Publicado: (2023)

C9orf72 intermediate expansions of 24–30 repeats are associated with ALS
por: Iacoangeli, Alfredo, et al.
Publicado: (2019)

Telomere length is greater in ALS than in controls: a whole genome sequencing study
por: Al Khleifat, Ahmad, et al.
Publicado: (2019)

2116. Impact of an Evidence-Based Intervention on Urinary Catheter Utilization in Switzerland
por: Schweiger, Alexander, et al.
Publicado: (2018)

A standard operating procedure for King’s ALS clinical staging
por: Balendra, Rubika, et al.
Publicado: (2019)

ALSgeneScanner: a pipeline for the analysis and interpretation of DNA sequencing data of ALS patients
por: Iacoangeli, Alfredo, et al.
Publicado: (2019)

Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017)

Coexistence of perseveration and apathy in the TDP-43(Q331K) knock-in mouse model of ALS–FTD
por: Kim, Eosu, et al.
Publicado: (2020)

2116. Long-term (2-year) outcomes and complications of COVID-19 in solid organ transplant (SOT) recipients
por: Burack, Daniel, et al.
Publicado: (2022)

Solution NMR Structure of Hypothetical Protein CV_2116 Encoded by a Viral Prophage Element in Chromobacterium violaceum
por: Yang, Yunhuang, et al.
Publicado: (2012)

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS
por: Crockford, Christopher, et al.
Publicado: (2018)

Genetic testing in ALS: A survey of current practices
por: Vajda, Alice, et al.
Publicado: (2017)

Optimizing Medium Components for the Maximum Growth of Lactobacillus plantarum JNU 2116 Using Response Surface Methodology
por: Yoo, Heeseop, et al.
Publicado: (2018)

PB2116: CASTLEMAN’S DISEASE: DIFFERENT CLINICAL BEHAVIOR AND PATHOLOGIC RECLASSIFICATION OF A COHORT OF MEXICAN PATIENTS
por: Collazo, Alfonso Orozco, et al.
Publicado: (2023)

A common haplotype within the PON1 promoter region is associated with sporadic ALS
por: Landers, John E., et al.
Publicado: (2008)

2116 Exploring Müller cell-cone interactions in human fovea using 3-dimensional volume electron microscopy (EM)
por: Singireddy, Ramya, et al.
Publicado: (2018)

The risk to relatives of patients with sporadic amyotrophic lateral sclerosis
por: Hanby, Martha F., et al.
Publicado: (2011)

A roadmap to ALS prevention: strategies and priorities
por: Benatar, Michael, et al.
Publicado: (2023)

Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia
por: El-Bab, Mohamed F, et al.
Publicado: (2012)

School’s Teachers Knowledge About Autism in Al-Badayacity, Al-Qassim Region, Kingdom of Saudi Arabia
por: Alharbi, Khalid Ali, et al.
Publicado: (2019)

The forensic implications of food hypersensitivity – a review of cases in United Kingdom courts: January 2014–February 2020
por: Gowland, MH, et al.
Publicado: (2022)

Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias
por: Mehta, Puja R, et al.
Publicado: (2019)

An Overview of MicroRNAs as Biomarkers of ALS
por: Joilin, Greig, et al.
Publicado: (2019)

PReS-FINAL-2116: Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists
por: Armbrust, W, et al.
Publicado: (2013)

Molecular dynamics analysis of superoxide dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progression
por: Kalia, Munishikha, et al.
Publicado: (2023)

A proposed staging system for amyotrophic lateral sclerosis
por: Roche, Jose C., et al.
Publicado: (2012)

Evaluation of factors leading to poor outcomes for pediatric acute lymphoblastic leukemia in Mexico: a multi-institutional report of 2,116 patients
por: Moreira, Daniel C., et al.
Publicado: (2023)

An Evaluation of a SVA Retrotransposon in the FUS Promoter as a Transcriptional Regulator and Its Association to ALS
por: Savage, Abigail L., et al.
Publicado: (2014)

Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS
por: Joilin, Greig, et al.
Publicado: (2019)

Demographics of cattle movements in the United Kingdom
por: Vernon, Matthew C
Publicado: (2011)

HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3
por: Sun, Jianrui, et al.
Publicado: (2022)

2116. Efficacy of CD388, a Novel Drug Fc-Conjugate (DFC), is Driven by the Small Molecule Neuraminidase Inhibitor (NAI)
por: Döhrmann, Simon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_90t8pmf1nk9bfkbr7bt1fli7po